ID: ALA59479

Max Phase: Preclinical

Molecular Formula: C16H15Cl2FO3

Molecular Weight: 345.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(/C=C/C=C(\C)COc1c(Cl)cc(F)cc1Cl)=C\C(=O)O

Standard InChI:  InChI=1S/C16H15Cl2FO3/c1-10(6-15(20)21)4-3-5-11(2)9-22-16-13(17)7-12(19)8-14(16)18/h3-8H,9H2,1-2H3,(H,20,21)/b4-3+,10-6+,11-5+

Standard InChI Key:  UBCGCKRYURMSNY-JYVCFQOWSA-N

Associated Targets(Human)

Cellular retinoic acid-binding protein I 14 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Retinoic acid receptor alpha 153 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 345.20Molecular Weight (Monoisotopic): 344.0382AlogP: 5.04#Rotatable Bonds: 6
Polar Surface Area: 46.53Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.32CX Basic pKa: CX LogP: 4.86CX LogD: 1.92
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.58Np Likeness Score: 0.40

References

1. Shealy YF, Riordan JM, Frye JL, Simpson-Herren L, Sani BP, Hill DL..  (2003)  Inhibition of papilloma formation by analogues of 7,8-dihydroretinoic acid.,  46  (10): [PMID:12723955] [10.1021/jm020324t]

Source